Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey C Nguyen

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
Neurogastroenterology and Motility|November 15, 2022
Impact of antegrade enema initiation on healthcare utilization in pediatric patients: A population-based cohort studyMichelle J Gould, Margaret A Marcon, Geoffrey C Nguyen, et al.
Inflammatory Bowel Diseases|June 19, 2019
The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel DiseaseLaura E Targownik, Eric I Benchimol, Julia Witt, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Inflammatory Bowel Diseases|October 23, 2018
Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness MethodologyAdam V Weizman, Geoffrey C Nguyen, Cynthia H Seow, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.
The American Journal of Gastroenterology|October 15, 2009
NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African AmericansThemistocles Dassopoulos, Geoffrey C Nguyen, Monica Vladut Talor, et al.
Angiology|April 16, 2020
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel StatementLuca Zanoli, Dimitri P Mikhailidis, Rosa Maria Bruno, et al.
Journal of the Canadian Association of Gastroenterology|December 5, 2022
Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort StudyCynthia H Seow, Stephanie Coward, Karen I Kroeker, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Neurogastroenterology and Motility|November 15, 2022
Impact of antegrade enema initiation on healthcare utilization in pediatric patients: A population-based cohort studyMichelle J Gould, Margaret A Marcon, Geoffrey C Nguyen, et al.
Inflammatory Bowel Diseases|June 19, 2019
The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel DiseaseLaura E Targownik, Eric I Benchimol, Julia Witt, et al.
The American Journal of Gastroenterology|January 3, 2020
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based AnalysisLaura E Targownik, Gilaad G Kaplan, Julia Witt, et al.
Inflammatory Bowel Diseases|October 23, 2018
Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness MethodologyAdam V Weizman, Geoffrey C Nguyen, Cynthia H Seow, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBDCharles N Bernstein, Harminder Singh, Sanjay K Murthy, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease CareJennifer L Jones, Eric I Benchimol, Charles N Bernstein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.
The American Journal of Gastroenterology|October 15, 2009
NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African AmericansThemistocles Dassopoulos, Geoffrey C Nguyen, Monica Vladut Talor, et al.
Angiology|April 16, 2020
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel StatementLuca Zanoli, Dimitri P Mikhailidis, Rosa Maria Bruno, et al.
Journal of the Canadian Association of Gastroenterology|December 5, 2022
Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort StudyCynthia H Seow, Stephanie Coward, Karen I Kroeker, et al.
Pageof 23